Intrinsic Value of S&P & Nasdaq Contact Us

CymaBay Therapeutics, Inc. CBAY

NASDAQ Global Select

SharesGrow Score
28/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

CymaBay Therapeutics, Inc. (CBAY) current share price is $32.48. The gold spot price is $4,825.20 per troy ounce. Using the formula: CBAY in gold = $32.48 × 31.1035 ÷ $4,825.20 = 0.2094 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of CBAY when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding CBAY shares over the measured period.

CBAY in US Dollars
Gold in US Dollars
CBAY in Gold (grams per share)

Real Wealth Growth Rate

CBAY
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{CBAY}_{\text{gold}}(t) = \frac{P_{\text{CBAY}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{CBAY}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{CBAY}_{\text{gold}}^{(T)}}{\text{CBAY}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{CBAY}_\text{gold}^{(0)}$ = initial gold-price, $\text{CBAY}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

KRTX
KRTX
Karuna Therapeutics, Inc.
$329.83
+0.03%
MDGL
MDGL
Madrigal Pharmaceuticals, Inc.
$524.99
-0.13%
ACLX
ACLX
Arcellx, Inc.
$114.89
+0.02%
TERN
TERN
Terns Pharmaceuticals, Inc.
$52.68
+0.13%
AKRO
AKRO
Akero Therapeutics, Inc.
$54.65
+0.00%
VKTX
VKTX
Viking Therapeutics, Inc.
$35.52
+1.46%
KNSA
KNSA
Kiniksa Pharmaceuticals, Ltd.
$46.92
-0.80%
GPCR
GPCR
Structure Therapeutics Inc.
$53.19
-1.95%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message